Detalhe da pesquisa
1.
Decreased Susceptibility to Dihydrofolate Reductase Inhibitors Associated With Genetic Polymorphisms in Ugandan Plasmodium falciparum Isolates.
J Infect Dis
; 225(4): 696-704, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34460932
2.
Associations between Varied Susceptibilities to PfATP4 Inhibitors and Genotypes in Ugandan Plasmodium falciparum Isolates.
Antimicrob Agents Chemother
; 65(10): e0077121, 2021 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34339273
3.
Changing Antimalarial Drug Sensitivities in Uganda.
Antimicrob Agents Chemother
; 61(12)2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28923866
4.
Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline.
Microbiol Spectr
; 11(3): e0523622, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37158739
5.
Face Burns: A 4-Year Experience.
J Burn Care Res
; 42(6): 1076-1080, 2021 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34136916
6.
Drug susceptibility of Plasmodium falciparum in eastern Uganda: a longitudinal phenotypic and genotypic study.
Lancet Microbe
; 2(9): e441-e449, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34553183
7.
Lead Optimization of Second-Generation Acridones as Broad-Spectrum Antimalarials.
J Med Chem
; 63(11): 6179-6202, 2020 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32390431
8.
Discovery and Structural Optimization of Acridones as Broad-Spectrum Antimalarials.
J Med Chem
; 62(7): 3475-3502, 2019 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30852885